WHO chief scientist urges people not to panic over Omicron
(Recasts with IMF chief's comments on possible economic impact)
* 40 countries find cases of Omicron variant
* 'We need to be prepared and cautious, not panic,' -WHO scientist
* IMF says it could downgrade growth projections
By Andrea Shalal
WASHINGTON, Dec 3 (Reuters) - The International Monetary Fund is likely to lower its global economic growth estimates due to the new Omicron variant of the coronavirus, the global lender's chief said at the Reuters Next conference on Friday in another sign of the turmoil unleashed by the ever-changing pandemic.
Omicron has spread rapidly to at least 40 countries since it was first reported in South Africa last week, officials say, and many governments have tightened travel rules to try to keep it out.
"A new variant that may spread very rapidly can dent confidence, and in that sense, we are likely to see some downgrades of our October projections for global growth," IMF Managing Director Kristalina Georgieva told the conference.
Much remains unknown about Omicron. Researchers said it could have picked up genetic material from another virus, perhaps one that causes the common cold, which would allow it to more easily evade human immune system defences.
Parts of Europe and the United States are grappling with a wave of infections of the more familiar Delta variant. The new strain could further destabilize economies that are still emerging from COVID-19 related lockdowns and disruptions.
A corporate Christmas party in the Norwegian capital Oslo resulted in at least 13 infections, making it the biggest outbreak outside of South Africa, officials said.
The World Health Organization's (WHO) chief scientist Soumya Swaminathan told Reuters Next that the fast-spreading variant would have to become more transmissible to out-compete Delta, which accounts for 99% of current transmissions.
"We need to be prepared and cautious, not panic, because we're in a different situation to a year ago," she said.
WHO's emergencies director Mike Ryan said there was no evidence that existing vaccines needed to be modified to fight Omicron. He said officials should work on getting more people inoculated with vaccines currently on the market.
"We need to focus on getting people most at risk vaccinated," Ryan said at a social media event.
However, WHO spokesman Christian Lindmeier told a United Nations briefing in Geneva that vaccine makers should prepare for the likelihood of adjusting their products.
Ugur Sahin, CEO of Germany's BioNTech 22UAy.DE , which makes a COVID-19 vaccine with Pfizer PFE.N , told Reuters Next Link company should be able to adapt the shots relatively quickly.
Sahin also said current vaccines should continue to provide protection against severe disease, despite mutations.
"I believe in principle at a certain timepoint we will need a new vaccine against this new variant. The question is how urgent it needs to be available," Sahin said.
WORRYING GAPS IN VACCINATION
Australia became the latest country to report community transmission of the new variant. Officials have found the new strain in 10 U.S. states, adding another challenge to a healthcare system that is already dealing with more COVID-19 illness caused by Delta.
More than 264 million people have been reported to be infected by the coronavirus since it was first detected in central China in late 2019 and 5.49 million people have died, according to a Reuters tally.
Cases in Europe, the pandemic's current epicentre, crossed the 75 million mark on Friday.
Vaccination rates vary from country to country but there are worrying gaps in poorer nations. Indonesia, the world's fourth most populous country and once Asia's COVID-19 epicentre, has fully inoculated only about 35% of its population.
In the United States, fewer than 60% of the population have been fully vaccinated, one of the lowest rates among wealthy nations.
Aside from wreaking havoc in the travel industry, the clampdown has pounded financial markets and undermined major economies just as they were beginning to recover from the lockdowns triggered by Delta.
Germany said it would bar the unvaccinated from all but essential businesses, and legislation to make vaccination mandatory would be drafted for early next year.
Several countries, including Britain and the United States, were bringing forward plans to offer booster shots, but, like travel bans, they are controversial.
Many scientists say the way to stop the virus spreading is to make sure poorer countries have access to vaccines, not to give blanket booster shots to people in richer countries.
GRAPHIC-Omicron variant map Link
The spread of COVID-19 variants of concern Link
GRAPHIC-COVID comeback caps a November to remember in markets
How South African scientists spotted the Omicron COVID variant
FACTBOX-Global travel curbs triggered by Omicron
FACTBOX-Global spread of Omicron cases
EXCLUSIVE-U.S. to extend transit mask mandate through mid-March -sources
Reporting by Reuters bureaux; Writing by Andy Sullivan, Stephen Coates and Nick Macfie; Editing by Angus MacSwan and Grant McCool
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.